Based on immunohistochemistry analysis of CD24 and CD44 expression in 50 breast cancer patients, Idowu MO also suggested that CD24-CD44+ BCSCs played a significant role in triple negative subtype of breast cancer [39]. The gene discussed is CD44; the disease is breast cancer.